asct patients stem relapsed post prior therapy eligible autologous refractory 
relapsed refractory disease therapy patients prior line treatment aml cell 
myeloma multiple criteria symptomatic standard according diagnosis diagnosed crab damage 
myeloma multiple diagnosis relapsed confirmed refractory therapy treatment prior patients 
myeloma imwg working international multiple group criteria diagnosis according diagnostic 
aml secondary therapy relapsed patients prior chemotherapy diagnosis related refractory 
